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Abstract 
Background: In the past six years, there has been a steady rise in the number of reported cases of 
chlamydia and gonorrhea in the United States. Expedited partner therapy (EPT) refers to the 
practice of treating partners of patients diagnosed with specific treatable sexually transmitted 
infections without first evaluating them. This treatment was recommended by the Centers for 
Disease Control and Prevention in 2006 and it is currently legalized in 45 states and the District 
of Columbia. However, many health care providers (HCPs) do not have knowledge of EPT 
therefore do not make use of it.  
Purpose: This quality improvement (QI) project provided education on expedited partner therapy 
to providers at a community health center in Maryland. The goal was to increase awareness and 
knowledge of expedited partner therapy, and the intention to utilize EPT to improve its use.  
Methods: Recruitment of the participants involved providing an overview of the project during 
staff meetings followed by sending emails to the clinicians. Pre and post intervention surveys 
were sent to clinicians via SurveyMonkey for data collection. The education intervention was 
through PowerPoint. 
Results: Using the Wilcoxon signed rank test, the intervention resulted in statistically significant 
results when current EPT use was compared to future plan to use EPT. Results for most of the 
other variables were not statistically significant. 
Conclusion: Increase knowledge and awareness of EPT can result in improved use. However, the 
outcome for most variables were not statistically significant, but future projects or studies could 
use larger samples to determine significance of the other variables. 
Keywords: Expedited partner therapy, sexually transmitted infections, chlamydia, 
treatment 
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Increasing Knowledge and Awareness of Expedited Partner Therapy among Providers 
 
Introduction 
 Expedited partner therapy (EPT) is the practice of treating partners of patients diagnosed 
with sexually transmitted infections (STIs) without first evaluating them (Centers for Disease 
Control and Prevention [CDC], 2020). In 2006, EPT was recommended by the CDC for the 
management of some treatable STIs (gonorrhea and chlamydia) in the United States (CDC, 
2020). Currently, EPT is permissible in 45 states, the District of Columbia, and the 
Commonwealth of the Northern Mariana Islands (CDC, 2020). While EPT is potentially 
allowable in four states as well as Puerto Rico and Guam, it is prohibited in South Carolina 
(CDC, 2020). Due to lack of knowledge of EPT, it is still underutilized by many health care 
providers (HCPs) who manage STIs despite legalization in most states. 
Background 
 There has been a steady increase in the number of reported cases of STIs in the United 
States. The CDC (2019) reported that in 2018, there were 1.8 million reported cases of 
chlamydia, a 19% rate increase since 2014: and 583,405 reported cases of gonorrhea, a 63% rate 
increase since 2014. In 2018, Maryland reported 35,482 reported cases of chlamydia, a 28% 
overall rate increase between 2014 and 2018 and 10,305 reported cases of gonorrhea, a 66% 
increase in the same time period (Maryland Department of Health [MDH], 2019). About 10-15% 
of women with untreated chlamydia will develop pelvic inflammatory disease which can lead to 
infertility (CDC, 2019). Therefore, the rise in STI cases both at the national and at the state level 
needs to be addressed. One option to address the STI burden is through creating awareness and 
increasing knowledge of EPT among providers and consequently increase EPT use.  
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Expedited partner therapy (EPT) use was recommended by the CDC more than a decade 
ago, therefore, there should be more widespread EPT use compared to what is reflected in 
practice (CDC, 2020). In Maryland, clinicians including licensed physicians, advanced practice 
nurses (APNs), physician assistants (PAs), and registered nurses (RNs) in local health 
departments are allowed to prescribe EPT (MDH, 2019). A quality improvement (QI) project 
was carried out at a federally qualified health center (FQHC) in Maryland to increase EPT 
awareness and knowledge among HCPs. The desired result of this DNP project is an increase in 
knowledge and intention to utilize EPT among clinicians at the FQHC.  
Problem Statement 
 The risk of sexually transmitted infections (STIs) in Maryland is indicated by high rates 
of treatable STIs, mainly chlamydia and gonorrhea. This is partially due to a lack of knowledge 
of EPT which leads to suboptimal utilization of EPT among HCPs despite the legalization of 
EPT in 45 states and the District of Columbia (CDC, 2020). Lack of EPT knowledge applies to 
many settings including the community health clinics in Maryland.  
Organizational “Gap” Analysis of Project Site 
The project was carried out at a community health clinic in Maryland. Informal 
interaction with the providers at one of the health clinics prior to project implementation revealed 
that most of the clinicians do not utilize EPT for patients diagnosed with chlamydia. The clinic 
has nurse practitioners as well as physicians in different specialties including 
obstetrics/gynecology (Ob/gyn), internal medicine (IM), and family practice (FP). An assessment 
conducted in one of the FQHC locations before implementing the project indicated that, although 
62.5% of the providers in that location were aware of EPT, only 25% of the providers prescribe 
EPT. Further investigation of the organization policies revealed that there is no written policy on 
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EPT. The analysis identified a gap in knowledge and policy formulation for EPT use. In addition, 
there were gaps in providers’ knowledge of EPT, the legal aspects of EPT, and dispensing 
procedures for EPT. Leichliter et al. (2016), emphasized that policies in public health have the 
potential to create a positive influence in many individuals’ lives at a relatively low cost. This QI 
project was carried out to address the gaps in knowledge of EPT. 
Review of Literature 
 For the literature search, two main databases PubMed and the Cumulative Index of 
Nursing and Allied Health Literature (CINAHL) were utilized. The search terms used in the 
literature were “expedited partner therapy”, “sexually transmitted infections”, “chlamydia 
treatment”. The initial search in CINAHL yielded 102 results, this was narrowed down with the 
inclusion criteria of publication date between 2015 and 2020, peer-reviewed articles, full text 
only, English only, adults only. The exclusion criteria were meta-analysis, editorials, and articles 
published before 2015. The final search yielded 10 articles, from which three articles were 
manually selected. Two of the articles were randomized controlled trials (RCTs) and the third 
one was an expert opinion report. The Johns Hopkins Nursing Evidence-based Practice guide 
was used to select relevant articles based on the level of evidence and quality. The RCTs were 
level II evidence, one was grade A because the study was large scale and the results can be 
generalized, and the other was grade C because more research was needed to determine 
effectiveness. The other one was level IV evidence, grade B because it was based on expert 
opinion report.   
The PubMed database was accessed with the same search terms used, “expedited partner 
therapy”, “sexually transmitted infections”, and “chlamydia treatment”. The inclusion criteria 
were, publication date between 2015 and 2020, peer-reviewed articles, full text only, English 
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only, adults only. The exclusion criteria used was similar to the one for CINAHL in that meta-
analysis, editorials, and articles published before 2015 were eliminated. The search initially 
yielded 24 articles, but it was narrowed down by using the term “chlamydia” and eliminating the 
word “treatment” from the search terms which yielded 15 articles. A manual selection was done 
to obtain seven articles based on the Johns Hopkins Nursing Evidence-based Practice guide for 
level of evidence and quality. One of the articles was an RCT, level II evidence, grade A. The 
other six were level III evidence, grade B or C because five of them were descriptive studies and 
one was a mixed method study. Based on the level of evidence, a total of ten peer reviewed 
publications were selected for the basis of this literature review. The information obtained is 
substantial to make conclusions about EPT. The report from the literature search is grouped into 
two different sections: facilitators and barriers of EPT use. 
Facilitators for EPT 
 A public health program that made free patient delivered partner therapy (PDPT) or free 
clinic stocks of EPT could increase awareness of EPT among providers, its distribution, and use 
(Golden et al., 2015; Oliver et al., 2016). This conclusion was made from two different RCTs 
carried out in Washington State and New York City (Golden et al., 2015; Oliver et al., 2016). 
The researchers also found that such programs are sustainable and could be applied to local 
health departments in other states (Golden et al., 2015; Oliver et al., 2016).  
State legislation and explicit institutional policies and guidelines regarding EPT can 
promote knowledge and awareness of EPT and subsequent use among clinicians (Pfennig, 2019; 
Rosenfeld et al., 2016). This was determined through an online survey on HCPs and from an 
expert opinion report (Pfennig, 2019; Rosenfeld et al., 2016). Since EPT is legal in most states 
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and permissible in many, health institutions should have clear policies regarding EPT to promote 
its use among clinicians.   
Current CDC guidelines recommend EPT use for heterosexual women and men and not 
for men who have sex with men (MSM) to treat gonorrhea and chlamydia (CDC, 2019). 
However, EPT can be used among gay, bisexual, men who have sex with men (GBMSM) as a 
prevention strategy as well as to decrease the rate of STIs among these populations (Clark et al., 
2017; Gamarel et al., 2019). These results were obtained from an RCT in Peru and a descriptive 
study that used a small convenience sample. A mixed method study from the Netherlands found 
other facilitators for increasing knowledge of EPT and its use include, providing home-based test 
kits, enabling providers to contact the patient by phone, allocating more time to providers for 
counseling, and providing more training to providers (Nanhoe et al., 2018).  
Barriers to EPT Use 
 Lack of knowledge and awareness among pharmacists and pharmacy staff was the main 
barrier to EPT use (Borchardt et al., 2018; Qin et al., 2018). This was determined through a 
cross-sectional study in Milwaukee (Borchardt et al., 2018) and a descriptive study that was done 
in Baltimore, Maryland (Qin et al., 2018).  Researchers found that 58% of the nameless EPT 
prescriptions were refused by pharmacies because of a lack of awareness of EPT (Borchardt et 
al., 2018). Increasing awareness among pharmacists and pharmacy staff can promote EPT use 
(Borchardt et al., 2018; Qin et al., 2018). 
Structural concerns (insurance and transportation) or limited accessibility to pharmacies, 
and differences in medication prices limit the use of EPT (Garamel et al., 2019; Qin et al., 2018). 
These concerns among patients need to be addressed in order to increase EPT utilization. A 
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public health EPT program which makes EPT accessible to HCPs can address this barrier as well 
(Golden et al., 2015; Oliver et al., 2016).   
Barriers such as prescriber’s legal responsibility, potential medication side effects, and 
barriers to privacy also hinder EPT use (Garamel et al., 2019; Wood et al., 2018). These results 
are based on descriptive studies that were carried out in the United States and Australia (Garamel 
et al., 2019; Nanhoe et al., 2018; Wood et al., 2018). According to Nanhoe et al. (2018), 
allocating more time for HCP counseling, enabling HCPs to communicate with the patient’s 
partner by phone, and educating HCPs on the legal aspects of EPT will address this barrier.  
Another barrier is the lack of legislation regarding EPT, this is evidenced by lack of clear 
policies on EPT in the Department of Defense (DoD) and the emergency department (ED) 
(Pfennig, 2019; Stidham et al., 2015). The clinicians who practice in these settings are not able to 
utilize EPT (Pfennig, 2019; Stidham et al., 2015). Therefore, clear organizational policies will 
enable the clinicians to utilize EPT as an additional measure to curb increasing STI rates. 
Study limitations 
There are some limitations in several of the studies.  Borchardt et al. (2018) noted that the 
customers requested to speak directly with the pharmacist, and this excludes the pharmacy 
technician. The implication is that the refusal rate for EPT prescriptions could be higher since 
pharmacy technicians may have less knowledge of EPT when compared to pharmacists 
(Borchardt et al., 2018). Nanhoe et al. (2018) noted a limitation whereby all the participants had 
special interest in STIs; therefore, their responses could have been biased toward the subject. 
However, this can also be seen as a strength because the participants have expertise in 
legislation, policies, and treatment of STIs (Nanhoe et al., 2018). It was also noted that recall 
bias could influence the self-reported information by supervising pharmacists or the pharmacist 
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on staff in the study on pharmacy level barriers that was done in Baltimore, Maryland (Qin et al., 
2018). Finally, results from this study cannot be generalizable to an area with lower STI burden 
(Qin et al., 2018). 
Summary  
 The rates of treatable STIs in the United States continue to rise despite the fact that EPT 
has been established as an option to treat partners and prevent reinfection from STIs (CDC, 
2019). Based on the review of the literature, some of the facilitators for EPT use include a public 
health program that provides free EPT which is accessible to HCPs (Golden et al., 2015; Oliver 
et al., 2016), state legislation and clear organizational policies (Rosenfeld et al., 2016), and 
allocating time for providers to do counseling (Nanhoe et al., 2018). The main barriers for EPT 
use are lack of knowledge and awareness of EPT guidelines among clinicians, pharmacists and 
pharmacy staff (Borchardt et al., 2018; Qin et al., 2018) and lack of explicit organizational 
policies on EPT (Pfennig, 2019; Stidham et al., 2015). Taking advantage of the facilitators and 
overcoming these barriers will increase awareness of EPT enhance its utilization.  
Evidence-based Practice 
 The literature review revealed that expedited partner therapy is not widely used due to 
lack of knowledge and awareness of the various aspects of EPT. Therefore, through the quality 
improvement (QI) project, the Doctor of Nursing Practice (DNP) student aimed to address the 
gap in knowledge and practice by implementing an education intervention among clinicians to 
increase awareness of EPT. The educational intervention addressed the general knowledge of 
EPT, the legal aspects, institutional policies, prescription procedures, pharmacy concerns, and 
patient counseling. 
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Theoretical Framework 
 Roger’s Diffusion of Innovation Theory emphasizes that an idea diffuses through a 
specific population and in the end, it is adopted resulting in a change in behavior (LaMorte, 
2019). According to the theory, LaMorte (2019) demonstrates that very few people are 
innovators, about one quarter of the population are early adopters, majority of the adopters lie in 
the middle of the curve, and about one quarter of the group are usually laggards. This is depicted 
in the diagram in Appendix A. The innovators are the first to try anything new and they are ready 
to take risks; early adopters enjoy leadership roles, they are aware of the need for change and 
have no problem trying new ideas (LaMorte, 2019). The early majority are rarely leaders, they 
usually need to see evidence that something works before they can try it while the late majority 
are skeptical and will only adopt an idea after it has been adopted by the majority (LaMorte, 
2019). Laggards are very conservative and very skeptical and sometimes it may take pressure 
from other adopters for them to agree with the new idea (LaMorte, 2019).  
According to LaMorte (2019), factors that will affect the process of adopting a new idea 
include relative advantage (is it better than the current idea?), compatibility (is it consistent with 
current values?), complexity (how easily it can be adopted), trialability (can it be tested before 
committing to adopt?), and observability (can the results be measured?). EPT measures up to 
these factors and can be easily adopted because, it is an additional resource to STI management; 
it is compatible with the values of STI treatment; it is not complex to adopt; it can be tried by a 
few HCPs before being adopted by the rest of the team; and the results can be measured by the 
number of clinicians who embrace the practice in the clinic. Based on Roger’s theory of 
Diffusion of Innovation, increasing awareness of EPT among clinicians in a community health 
clinic will lead to a few adopting the idea initially, but over time majority will adopt it resulting 
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in comprehensive EPT knowledge and use within the health center. Eventually, the idea can be 
adopted by other clinics and health care centers.  
Methods 
Online pre/post-surveys were the main tools for collecting data for the QI project. The 
education intervention was in the form of PowerPoint presentation on EPT. The main method of 
data collection was quantitative. There was a general comments section at the end of the post-
survey which would generate qualitative data. 
Goals, objectives, and outcomes 
The goal of the DNP project was to increase knowledge and awareness and create a change in 
attitude regarding EPT among providers. To achieve the goal, an evidence-based educational 
quality improvement project on EPT was implemented and evaluated among providers. This 
included an online pre/post intervention survey which is available in Appendix C. Also, an 
education intervention in form of a PowerPoint presentation was provided so that the HCPs were 
able to access it at their own convenient time. The link for the PowerPoint is attached in 
Appendix D. The objectives and expected outcomes are outlined in the table below. 
 
Objective  Expected Outcome 
-A 10-minute online pre-survey would be 
made available for clinicians during the 
months of February 2021 
-At least 85% of the clinicians would 
complete the online survey 
 
- 15-minute educational presentations in form 
of PowerPoint would be made available 
online during the months of February 2021 
for clinicians to access and review at their 
own convenience 
- At least 85% of the clinicians would 
access and review the PowerPoint 
presentations on EPT 
-A 10-minute online survey would be made 
available to clinicians during the months of 
February to March 2021 
-At least 85% of the clinicians would 
complete the post-intervention survey 
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Project Site and Population 
The project was implemented at a federally qualified health center (FQHC) in the 
Northeast. The health centers provide primary care services including preventive services and 
management of chronic conditions; women health services; mental health services which include 
substance use disorders, and urgent care services to underserved communities in the area. These 
communities have limited access to preventive health services and the residents tend to have 
higher rates of many chronic medical conditions and STIs.  
The QI project targeted clinicians from different areas of specialization including family 
practice (FP), internal medicine (IM), obstetrics/gynecology (Ob/Gyn), and pediatrics. 
Physicians, nurse practitioners, and physician assistants were involved in the project. The 
expected outcome was increase in knowledge and awareness of EPT among clinicians.  
Measurement Instruments 
 In order to measure the outcomes of the QI project, an online survey was administered 
via SurveyMonkey. The survey was formulated to collect information on the clinician’s 
demographics, knowledge of EPT, utilization of EPT, barriers, and facilitators for EPT use. The 
survey was adopted from an established tool that was previously used in a qualitative study in 
Pittsburgh, Pennsylvania (PA) to determine the perspectives of HCPs on EPT for chlamydia 
(Rosenfeld et al., 2016).  
Prior to using the survey in the study in Pittsburgh, it was reviewed by two experts in STI 
testing and five public health researchers, in addition, the survey was piloted on two HCPs to 
assess its clarity (Rosenfeld et al., 2016). The tool has a high sensitivity rate because the 
surveyor can use it to successfully determine the knowledge, use, barriers, and facilitators for 
EPT use among clinicians. In addition, the tool has a favorable specificity rate because it can also 
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clearly identify the clinicians with limited knowledge and use of EPT. Therefore, this tool is 
considered valid. Permission to use the survey tool for this QI project was obtained through an 
online request (Appendix B).  
Implementation Plan/Procedure 
 Participants were informed of the intended project during a staff meeting and an email 
was sent to the potential participants. A pre-intervention online survey was distributed via 
SurveyMonkey to the clinicians, and it was available for a period of one month. The education 
intervention was made available one week after completing the presurvey and was accessible for 
review over one month. A post-intervention online survey was sent via SurveyMonkey two 
weeks after the pre-survey, and it was available for period of four weeks.  
Knowledge of EPT was assessed using True/False/I don’t know statements. Most of the 
other responses were on a five-point Likert scale with the following items: strongly agree, agree, 
neutral, disagree, and strongly disagree. Baseline information on knowledge and utilization of 
EPT was collected before the intervention and this was available for four weeks with a weekly 
automated reminder sent out for those who hadn’t completed it. The PowerPoint presentation, 
located in Appendix D, was made available one week after the pre-survey was sent out. The 
PowerPoint presentation was available for four weeks for review by HCPs. Thereafter, at four 
weeks post-intervention, the survey was available via SurveyMonkey to be completed by the 
HCPs to determine the effectiveness of the intervention (Appendix C). 
Data Collection Procedures 
An online survey was administered to HCPs at two locations of a federally qualified 
health center (FQHC) in Maryland. The DNP student used SurveyMonkey to administer the 
survey that collected data on demographics, knowledge of EPT, barriers, facilitators, and EPT 
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use. The post-survey that was used can be located under Appendix C. An interactive presentation 
was not possible as previously intended and planned due to conflicting schedules and many 
competing priorities resulting from the current COVID 19 pandemic.  
Data Analysis 
The IBM Statistical Package for the Social Sciences (SPSS) software version 27.0 was 
used for data analysis. This software has been used and proven effective in analyzing trends and 
determining conclusions in various projects and research studies (Gardner, 2020). Wilcoxon 
signed-rank test, a non-parametric statistic, was used to compare responses to the pre/post survey 
and to determine relationships. Descriptive statistics were used to compute frequencies. 
Cost-Benefit Analysis 
 Majority of the cost for this project was in the form of time (donated time) spent by the 
DNP student on the pre/post-intervention surveys, creating a PowerPoint presentation on EPT for 
clinicians, and collecting and analyzing the data. The time was in form of donated time since it 
was part of the coursework for the DNP student. There was no monetary cost incurred since 
everything was online. A detailed table of the cost-benefit analysis can be located at Appendix E. 
The benefits of the QI project include an increased knowledge and awareness of EPT among 
clinicians at the community health clinic, and consequently improvement in EPT use in the 
future to address STI management.  
Ethical considerations and Protection of Human Subjects 
The project was approved by the leadership at the site on 10/9/2020 but the letter of 
support was issued two months later, the late approval was due to the current pandemic and new 
projects being placed on hold. The University of Massachusetts, Amherst, Internal Review Board 
(UMass IRB) approval was obtained prior to initiating the DNP project (Appendix F). A delay in 
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obtaining a letter of approval resulted in a delay in the project implementation. The project 
involved clinicians who completed online surveys regarding EPT. They also participated in the 
PowerPoint presentation. Prior to conducting the surveys, consent (Appendix G) was obtained 
from the clinicians and this was included at the beginning of the survey. The consent also 
provided detailed instructions of what the survey involved.  
There were no risks associated with participation in the QI project, and the responses to 
the survey were made anonymous to maintain the confidentiality of the clinicians. This is in 
accordance with HIPAA rules of privacy and confidentiality. The DNP student was in charge of 
the storage, retrieval and safeguarding of all data and survey responses for the project. 
Information was coded using random individual identification numbers to maintain anonymity. 
The report from the QI project was kept in online electronic files which were accessible by a 
password and there was no individual identifiable information. During analysis, the data obtained 
from the survey responses was coded using random individual identification numbers to maintain 
anonymity. 
Results 
 The purpose of the project was to increase knowledge and awareness of expedited partner 
therapy among providers. The project was carried out at two locations of a FQHC in Maryland. 
Twelve clinicians participated in the pre-survey and seven in the post-survey. The participation 
goal was 85% which translates to 15 out of the target of 20 participants, but in this project, 60% 
(12 out of 20) participated in the presurvey and only 35% (7 out of 20) participated in the post-
survey. The project involved a pre-survey, education intervention, and post survey. The 
clinicians had varying years of experience from less than five to more than 20 years of practice, 
they were from different specialties, and majority of them were female.  
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Results based on frequency distribution indicate that all the participants agreed that 
concern about medication allergies was the main barrier for EPT use. Also, 58% of the presurvey 
and 71% postsurvey participants agree that liability was another barrier, and this is closely 
related to medication allergies. Surprisingly, 42% of the participants for both pre/post survey 
viewed time constraint as a barrier for EPT use and the rest were either neutral on the issue or 
disagreed with it. In regard to the facilitators for EPT use, 58% of the presurvey and 71% of the 
postsurvey participants agreed that institutional guidelines on EPT use were important.  
However, 92% of the presurvey and 85% of the postsurvey participants agreed that EPT training 
was important. It was unexpected that only 42% of participants viewed time constraints to be a 
barrier. These results can be located in Appendix H (Tables 3-12).  
 Using the Wilcoxon signed-rank test, the intervention resulted in statistically significant 
results when current EPT use was compared to future plan to use EPT. However, the intervention 
did not create statistically significant results when comparing the pre and post intervention 
results for most of the other variables related to knowledge of EPT such as legal status, 
prescription requirements, and billing for EPT. These results are shown in the table below.  
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Table 1: Comparison of knowledge variables pre/post  
NPAR TESTS  
/WILCOXON=pre1 pre2 pre4 pre5 pre14 WITH post1 post2 post4 post5 post14 (PAIRED) 
 /STATISTICS DESCRIPTIVES /MISSING ANALYSIS. 
 
 
The Wilcoxon signed-rank test result was (p = 0.042, Z= -2.032) with a confidence interval (CI) 
of 95%, these results are statistically significant, meaning there was a change in attitude toward 
EPT use as a result of the education intervention. 
 Based on the statistical analysis using Wilcoxon signed-rank test, the variables that 
represent facilitators and barriers in Table 2 below did not have significant results when a 
comparison was done before and after the intervention. 
Table 2: Comparison of variables related to facilitators and barriers pre/post 
NPAR TESTS /WILCOXON=pre8 pre9 pre10 pre11 pre12 WITH post8 post9 post10 post11 post12 (PAIRED) 
  /STATISTICS DESCRIPTIVES QUARTILES /MISSING ANALYSIS. 
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The above results indicate that the clinicians’ views towards the facilitators and barriers for EPT 
use preintervention compared to post-intervention do not have much impact on the use of EPT. 
Discussion 
The results from the project strongly imply that an increase in knowledge and awareness 
of EPT among providers will result in increased use of EPT. This is supported by the outcome of 
the project which indicate that the education intervention resulted in a change in attitude toward 
EPT use. Using the Wilcoxon signed rank test for statistical analysis the results were (p = 0.042), 
which can be interpreted that as a result of the project, more clinicians planned to use EPT. 
Therefore, the results from the project confirm the literature findings which concluded that 
increase in knowledge and awareness of EPT is one way to improve its use.  
In relation to Roger’s Diffusion of Innovation Theory, there were a few innovators who 
were already using EPT before the project was initiated. When the other clinicians learned about 
it, they got interested in the idea of EPT use and by the end of the brief project, more clinicians 
became adopters. Early and late majority clinicians who were hesitant and only committed to 
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rarely use EPT due to other influencing factors such as liability. However, as EPT use becomes 
widespread in the entire organization, it is predicted that they will adopt the practice. Laggards 
are the clinicians who will be last to adopt the new practice when it becomes common practice in 
the organization.  
Barriers and facilitators that may influence EPT use need to be controlled even though 
the results for these variables were not statistically significant in this project. The outcome was 
not significant likely because the sample was small. The facilitators for EPT use such as having 
clear institutional guidelines and training on its use should be addressed. Training will provide a 
common and clear understanding on how to prescribe and dispense EPT, and clear policy and 
guidelines will address any liability concerns that may arise. The three main barriers for EPT use 
include a concern about medication allergies and possible interactions, liability associated with 
treating a patient who is not known to the provider, and time constraints.  
The concern about medication allergies implies that it is challenging for a clinician to 
prescribe medications to a patient when the allergies are unknown or the interaction that may 
occur with that patient’s current medications. Liability was the other barrier which is closely 
related to the medication allergies and refers to the provider not knowing the recipient’s medical 
history, current medications, and medication allergies. Therefore, in case of any allergic reaction, 
the provider may be liable because of providing a prescription without adequate assessment. 
Time constraints play a role because additional time not allocated in the clinician’s schedule may 
be needed to prescribe and provide any necessary education materials for partner review.  
Project Limitations 
The competing priorities and time constraints which have been heightened by the 
pandemic were evident during project implementation, and this led to the low number of 
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participants for the project. Also, the planned interactive education intervention was not possible 
due to conflicts in clinician schedules and various competing priorities stated earlier. These may 
have impacted the results for most variables that may influence EPT use not being statistically 
significant, the small sample size may have affected the results of the project as well. Despite the 
limitations, a facilitator for the project was the fact that EPT was not a totally new idea and some 
of the clinicians were using it in their current practice. Therefore, future studies can use a more 
interactive intervention and a larger sample to determine if the results will be of statistical 
significance. 
Conclusion 
In summary, the project showed that increased knowledge and awareness of EPT among 
HCPs will result in improved use of EPT for better management of STIs. In addition to 
increasing awareness and knowledge of EPT, the following factors need to be addressed, having 
clear organizational policies on EPT, addressing the barriers such as liability, medication allergy 
concerns, and time constraints for clinicians. Despite the unforeseen and unexpected challenges, 
it is clear that increasing knowledge and awareness on EPT can result in enhanced EPT use 
among clinicians. Although the results from this project cannot be generalized to other settings, 
they can serve as a foundation or starting point for future studies. Furthermore, I would 
recommend that future studies include larger sample sizes and improve on the techniques of 
presenting the intervention to the providers. These may help to affirm current findings or prove 
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Appendix A: Theoretical Framework 
Diffusion of Innovation Theory 
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Appendix B: Permission for Survey 
The link to the permission obtained to use the survey tool which is included in the article.   
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Appendix C: Measurement 
Pre/post-intervention Survey 
Part 1: Demographics 
Demographics  Response 
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Part 2: Expedited Partner Therapy Pre/Posttest 
1. Expedited partner therapy (EPT) is legal in 45 states and the District of Columbia. True 
or False or I don’t know 
2. Expedited partner therapy was recommended by the Centers for Disease Control and 
Prevention (CDC) in 2010. True or False or I don’t know 
3. Expedited partner therapy is legal in Maryland. True or False or I don’t know 
4. My clinic has a policy on EPT. True or False or I don’t know 
5. The following describes the eligibility criteria for Expedited partner therapy. Select ALL 
that apply 
a. Sex partners within the past 60 days prior to diagnosis 
b. Pregnant women 
c. Only one partner is eligible 
d. No limit to the number of partners 
6. If the partner’s name is unknown, “EPT” is sufficient on the prescription. True or False 
or I don’t know 
7. The patient’s insurance can be billed for Expedited partner therapy. True or False or I 
don’t know 
8. “EPT” or “Expedited Partner Therapy” must be included in the prescription. True or 
False or I don’t know 
 
The following statements are meant to assess barriers and facilitators for expedited 
partner therapy using a Likert scale of 1-5 with 1= strongly disagree and 5 = strongly 
agree 
 
9. Prescribing treatment for Sexually Transmitted Infections for a sexual partner(s) who is 
not your patient(s). 1. Strongly disagree 2. Disagree 3. Neutral 4. Agree 5. Strongly 
agree 
10. Knowledge about institutional guidelines is important in EPT use. 1. Strongly disagree 
2. Disagree 3. Neutral 4. Agree 5. Strongly agree 
11. Training on how to provide EPT is an important factor. 1. Strongly disagree 2. Disagree 
3. Neutral 4. Agree 5. Strongly agree 
12. Time constraint is a factor in deciding whether or not to use EPT. 1. Strongly disagree 2. 
Disagree 3. Neutral 4. Agree 5. Strongly agree 
13. Knowledge about intimate partner violence is important when deciding whether or not to 
prescribe EPT. 1. Strongly disagree 2. Disagree 3. Neutral 4. Agree 5. Strongly agree 
14. Liability is a concern when you plan to use EPT. 1. Strongly disagree 2. Disagree 3. 
Neutral 4. Agree 5. Strongly agree 
15. Medication allergies are a concern when prescribing EPT. 1. Strongly disagree 2. 
Disagree 3. Neutral 4. Agree 5. Strongly agree 
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This last question assesses the likelihood of expedited partner therapy use on a Likert 
scale of 1-5 with 1= Never and 5 = Always 
 
16. On a scale of 1-5 how likely are you to use EPT? 1. Never 2. Rarely 3. Sometimes 4. 
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Appendix D: Education Intervention  
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Appendix E: Cost-Benefit Analysis 
Estimated cost of the QI project will be in form of donated time provided in kind by the DNP 
student: 
Compiling the online survey: 4 hours x $ 60 / hour = $240 
Development of a PowerPoint presentation: 4 hours x $ 60 / hour = $240 
  Data collection: (20hrs/month x1 month) = 20 hours x $ 60 / hour = $1200 
Data Analysis: (5 hours/day x7 days) = 35 hours x $60 / hour = $2100 
Presentation of the results: 2 hours x $ 60 / hour = $120 
Total cost = $3,900 
There was no monetary cost associated with this project since the project was entirely online.  
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Appendix G: Consent Form 
You are being invited to participate in a quality improvement (QI) project titled, “Increasing 
Knowledge and Awareness of Expedited Partner Therapy among Providers”. This QI project is 
being done by Angeline K. Motari, DNP student from the University of Massachusetts, Amherst. The 
purpose of this project is to increase knowledge and awareness of expedited partner therapy (EPT) among 
providers and create a change in attitude among providers regarding EPT. If you agree to participate in 
the project, you will be asked to complete an online survey/questionnaire (pre-survey), also participate in 
an education intervention regarding EPT, and then a post-survey. 
By clicking agree below, you are indicating that you are at least 18 years old, have read and understand 
the consent form and you agree to participate in the quality improvement project. 
o I agree to terms and conditions 
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Appendix H: Frequency Tables 
 
Table 3: Presurvey                                                      Table 4: Post-survey 
                           
Table 5: Presurvey                                                     Table 6: Post-survey 
                       
Table 7: Presurvey                                                     Table 8: Post-survey 
 
                      
Table 9: Presurvey                                                   Table 10: Postsurvey 
                                 
Table 11: Presurvey                                             Table 12: Postsurvey 
                   
